Ligand profile
ZINC1616708
Virtual-screening candidate from ZINC.
Bound to: KP13_05515 — Aminotransferase, class V domain-containing protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC1616708- UniProt (similar protein)
Q7PRG3- Tanimoto
- 0.618
- Target protein
- KP13_05515
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 80.4
- −1 ≤ LogP ≤ 5 2.78
- MW ≤ 500 Da 269.3
- LogP ≤ 5 2.78
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 80.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1ccccc1C(=O)CCc1ccccc1C(=O)ONc1ccccc1C(=O)CCc1ccccc1C(=O)O
InChI=1S/C16H15NO3/c17-14-8-4-3-7-13(14)15(18)10-9-11-5-1-2-6-12(11)16(19)20/h1-8H,9-10,17H2,(H,19,20)InChI=1S/C16H15NO3/c17-14-8-4-3-7-13(14)15(18)10-9-11-5-1-2-6-12(11)16(19)20/h1-8H,9-10,17H2,(H,19,20)
ZPMRSROIKFOUBJ-UHFFFAOYSA-NZPMRSROIKFOUBJ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- KY1
- Homolog
- Q7PRG3
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC1616708 →
- ZINC ZINC20 ZINC1616708 →
- UniProt UniProt Q7PRG3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC1616708”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05515.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 20
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).